| SC 13G/A | 2024-04-09 | JPMORGAN CHASE & CO | Revance Therapeutics, Inc. | 2,768,691 | 2.6% | EDGAR |
| SC 13G/A | 2024-02-14 | Palo Alto Investors LP | Revance Therapeutics, Inc. | 5,237,284 | 6.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Antara Capital LP | Revance Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Revance Therapeutics, Inc. | 5,069,625 | 5.8% | EDGAR |
| SC 13G/A | 2024-02-13 | Polar Capital Holdings Plc | Revance Therapeutics, Inc. | 3,169,239 | 3.6% | EDGAR |
| SC 13G/A | 2024-02-09 | GIC Private Ltd | Revance Therapeutics, Inc. | 5,825,881 | 6.6% | EDGAR |
| SC 13G/A | 2024-02-09 | Capital World Investors | Revance Therapeutics, Inc. | 11,939,076 | 13.6% | EDGAR |
| SC 13G | 2024-02-06 | FRANKLIN RESOURCES INC | Revance Therapeutics, Inc. | 6,108,277 | 6.8% | EDGAR |
| SC 13G/A | 2024-01-25 | JPMORGAN CHASE & CO | Revance Therapeutics, Inc. | 4,754,771 | 5.4% | EDGAR |
| SC 13G/A | 2024-01-25 | JPMORGAN CHASE & CO | Revance Therapeutics, Inc. | 4,754,771 | 5.4% | EDGAR |
| SC 13G/A | 2024-01-25 | BlackRock Inc. | Revance Therapeutics, Inc. | 7,453,371 | 8.5% | EDGAR |
| SC 13D/A | 2023-10-24 | Teoxane SA | Revance Therapeutics, Inc. | 6,550,800 | 7.4% | EDGAR |
| SC 13D | 2023-09-01 | Teoxane SA | Revance Therapeutics, Inc. | 4,445,800 | 5.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Palo Alto Investors LP | Revance Therapeutics, Inc. | 5,283,609 | 6.4% | EDGAR |
| SC 13G | 2023-02-14 | Polar Capital Holdings Plc | Revance Therapeutics, Inc. | 4,848,633 | 5.9% | EDGAR |
| SC 13G | 2023-02-14 | Antara Capital LP | Revance Therapeutics, Inc. | 5,239,600 | 6.4% | EDGAR |
| SC 13G/A | 2023-02-13 | Capital World Investors | Revance Therapeutics, Inc. | 9,480,156 | 11.5% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Revance Therapeutics, Inc. | 4,496,316 | 5.5% | EDGAR |
| SC 13G/A | 2023-02-09 | GIC Private Ltd | Revance Therapeutics, Inc. | 5,492,965 | 6.7% | EDGAR |
| SC 13G/A | 2023-02-03 | BlackRock Inc. | Revance Therapeutics, Inc. | 7,072,681 | 8.6% | EDGAR |